Mia's Feed
Medical News & Research

MRI May Soon Replace Painful Spinal Tap for Faster Multiple Sclerosis Diagnosis

MRI May Soon Replace Painful Spinal Tap for Faster Multiple Sclerosis Diagnosis

Share this article

2 min read

Recent research from the University of Nottingham suggests that magnetic resonance imaging (MRI) can effectively diagnose multiple sclerosis (MS), potentially eliminating the need for the traditional, often painful lumbar puncture. MS, a neurological disorder affecting approximately 150,000 individuals in the UK, is notoriously difficult to diagnose because its symptoms vary widely and can mimic other conditions. Currently, diagnosis often involves a standard MRI scan coupled with a lumbar puncture, where a needle is inserted into the lower spine to extract cerebrospinal fluid for testing. This procedure can be painful and sometimes leads to complications requiring hospitalization or additional recovery time. Moreover, not all MS cases show abnormal findings in the cerebrospinal fluid, and similar findings can occur in other diseases, leading to possible misdiagnoses.

The breakthrough comes from a study published in Neurology Open Access, where researchers demonstrated that an 8-minute MRI scan, specifically a T2*-weighted MRI, can identify characteristic MS lesions in the brain’s white matter, centered around veins—an indicator known as the "central vein" sign. Researchers developed a "rule of six," where detecting six lesions with a central vein reliably confirmed MS diagnosis, potentially avoiding the need for invasive lumbar puncture tests. Patients with suspected MS underwent both MRI scans and lumbar punctures; after 18 months, the MRI-based diagnosis closely matched the clinical outcomes, supporting its efficacy.

This finding has already influenced international MS diagnostic guidelines. The International Committee for the Diagnosis of MS now recognizes the MRI method as sufficient for diagnosis, making lumbar punctures unnecessary in many cases. This advancement offers many benefits: it is safer, quicker, and more comfortable for patients, eliminating the risks associated with lumbar punctures. The MRI procedure takes just 8 minutes, after which patients can often return home immediately. According to Professor Nikos Evangelou, this approach could enable earlier diagnoses—on average three months sooner—and save the NHS up to five million pounds annually, funds that could be directed toward better patient care.

In summary, this innovative MRI technique provides a less invasive, more cost-effective, and faster method to diagnose MS, which could revolutionize current diagnostic practices and improve patient experience.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Molecular Testing Steers Personalized Chemotherapy for Advanced Prostate Cancer Patients

New research demonstrates that tumor gene expression profiling can predict which advanced prostate cancer patients will benefit from chemotherapy, improving survival and reducing unwarranted side effects. Published in *Cell*, the study validates molecular testing as a powerful tool to personalize treatment strategies.

Targeting a Single Gene Shows Promise in Reversing Cognitive Challenges in 22q11.2 Deletion Syndrome

New research highlights how reducing EMC10 protein levels could restore brain function and improve cognition in models of 22q11.2 Deletion Syndrome, opening doors for targeted therapies.

Advances in Precision Therapy for HR+/HER2- Breast Cancer: Key Findings from Recent Study

New research from Roswell Park uncovers markers that predict response to CDK4/6 inhibitors in HR+/HER2- metastatic breast cancer, advancing personalized treatment options.

Advancements in 3D Bioprinting of Brain Vessels Mimic Human Blood Flow Dynamics

A novel 3D bioprinting approach creates realistic brain vessel models to study blood flow patterns and cerebrovascular diseases, opening new horizons in disease research and treatment strategies.